The multifunctional anti-apoptotic Bcl-2-associated athanogene (Bag-1) protein is overexpressed in multiple cancer types, including breast cancer, and is a potential drug target for cancer treatment [2–4]. The gene discussed is BAG1; the disease is breast carcinoma.